Patent intelligence · US
US 9980999
Method for producing dry extracts
Method for producing dry extracts
Patent details — US 9980999
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 29, 2018
- Expiration
- May 24, 2038
- Applicant
- Binorica SE
- Claims
- 26
- CPC classes
- A61K, A61K2236/33, A61K36/185, A61K36/35
Quick answer
US 9980999 (Method for producing dry extracts) is held by Binorica SE. Status: granted. Granted May 29, 2018. Expires May 24, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Binorica SE
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61K, A61K2236/33, A61K36/185, A61K36/35, A61K36/515, A61K36/70
More from Binorica SE
Related pharmaceutical patents in our USPTO index.
-
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12239729
TRPV3 agonists for the treatment of skin conditions
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12018043
CD73 inhibitors
granted -
US 12005080
Method for promoting proliferation of immune cells
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11807658
CD73 inhibitors
granted
Frequently asked questions
What is US patent 9980999?
US 9980999 (Method for producing dry extracts) is held by Binorica SE. Status: granted. Granted May 29, 2018. Expires May 24, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9980999?
Binorica SE is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 52 pharmaceutical patents for this assignee.
When does US 9980999 expire?
Our index shows an expiration date of May 24, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.